ARISTADA INITIO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Apr 2024)
What this means for you
Registered since 09 Oct 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87276061
- Registration number
- 5581432
- Mark type
- Stylized text
- Filed
- 21 Dec 2016
- Published for opposition
- 21 Feb 2017
- Registered
- 09 Oct 2018
- Attorney of record
- Norm J. Rich
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
Owner
- Alkermes Pharma Ireland Limited, DUBLIN 4, IE
- Alkermes Pharma Ireland Limited, DUBLIN 4, IE
- Alkermes Pharma Ireland Limited, DUBLIN 4, IE
Prosecution history
- 08 Apr 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Apr 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Oct 2023 — TEAS SECTION 8 & 15 RECEIVED
- 09 Oct 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Oct 2018 — REGISTERED-PRINCIPAL REGISTER
- 04 Sept 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Sept 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Aug 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Jul 2018 — USE AMENDMENT FILED
- 14 Aug 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Jul 2018 — TEAS STATEMENT OF USE RECEIVED
- 26 Jan 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jan 2018 — SOU EXTENSION 2 GRANTED
- 24 Jan 2018 — SOU EXTENSION 2 FILED